Autoimmune, Infectious, and Metabolic NCSE/NCS


Antibody

Seizure predominance

Prevalence in the epilepsy population

Associated tumors

VGKC (includes LGI1 and CASPR2)

Major feature (80–90 % of cases)

6.5–11.5 %

Ovarian teratoma, thymoma

NMDA receptor (may have more diffuse involvement of the CNS)

Major feature (70–80 % of cases)

2.5–7 %

Ovarian teratoma

AMPA

Minor feature (up to 40 %)
 
Small cell lung cancer, breast cancer, thymoma

GABA-B

Major feature (80–100 %)
 
Small cell lung cancer

mGluR5

Minor feature
 
Hodgkin lymphoma

GAD65

Major feature

1.6–8.7 %

Small cell lung cancer

ANNA-1 (Hu)

Minor feature
 
Small cell lung cancer

Ma 1/2

Minor feature
 
Ma1: lung, renal, skin, gastrointestinal

Ma2: germ cell (males)


Modified from Correll [3], Springer publication

Abbreviations: ANNA-1 anti-neuronal nuclear antibodies-1 (ANNA-1), GAD glutamic acid decarboxylase (GAD65), VGKC voltage-gated potassium channel, NMDA N-methyl-d-aspartate, AMPA alpha-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid, GABA gamma-aminobutyric acid, mGluR5 metabotropic glutamate receptor 5, LGI1 leucine-rich glioma-inactivated 1 protein, CASPR2 contactin-associated protein 2



Often patients with limbic encephalitis present with a combination of seizures, psychiatric disturbances, abnormal movements, and autonomic disturbances. The presentation may vary by age with more movement and speech disorders seen in children and more memory disturbances and autonomic disturbances seen in older patients. The specific clinical presentations for the specific antibody-mediated encephalitis are presented in Table 2.


Table 2
Common presentations of the specific antibody-mediated limbic encephalitis












































Antibody

Clinical presentation

Seizure typesa

VGKC

Impaired episodic memory, confusion and disorientation, behavioral changes such as aggression and agitation, psychotic symptoms such as hallucinations, seizures, and low sodium secondary to SIADH

Complex partial and generalized tonic–clonic, mesial temporal or hippocampal foci more common than extratemporal – faciobrachial dystonic seizures in 90 % of LGI1 cases

NMDAR

Stage 1: psychiatric symptoms including hallucinations, psychosis, depression, and anxiety; confusion; memory deficits and amnesia; aphasia; and seizures

Stage 2: reduced consciousness, oro-lingual-facial dyskinesias and choreoathetoid movements, dysautonomia including tachycardia/brachycardia and labile blood pressure, and central hypoventilation

Simple partial, complex partial, and generalized tonic–clonic, which can be localized temporally, extratemporally, or multifocally

AMPA

Short-term memory loss, confusion, behavioral changes, agitation/aggression, and hypersomnolence or decreased consciousness

Temporal seizures

GABA-B

Memory deficits, behavioral changes, sleep disturbances, psychosis, and aphasia

Temporal seizures

mGlu5R

Confusion, short-term memory loss, emotional lability, hallucinations, and delusions

Temporal seizures

Myoclonic jerks

GAD-65

Short-term memory loss, behavioral changes such as anxiety, and seizures

Temporal lobe seizures

ANNA-1

New onset seizures, memory loss, and psychiatric disturbance

Temporal and extratemporal seizures

Epilepsia partialis continua

Ma1/2

Memory loss, psychiatric disturbances and seizures

Temporal seizures


From Correll [3]

aAll of these antibody-mediated encephalitides may be present with NCS/NCSE



Evaluation


The workup of patients with suspected autoimmune etiology should include a magnetic resonance imaging (MRI) scan of the brain, EEG, and lumbar puncture. In patients with anti-N-methyl-d-aspartate (NMDA) receptor encephalitis, MRI abnormalities consisting of nonspecific lesion are seen in 30 % of cases, EEG is abnormal in 90 %, of cases and CSF may show elevated oligoclonal bands. Blood and cerebrospinal fluid (CSF) samples to screen for paraneoplastic and autoimmune antibodies should be obtained. Several companies offer panels of tests for these antibodies. Markers of inflammation like erythrocyte sedimentation rate (ESR), C-reactive protein, and von Willebrand factor antigen may help determine the burden of the inflammatory process. At times, further testing is needed to exclude other etiologies that may be considered in the differential diagnosis of limbic encephalitis including herpes simplex virus (HSV) and human herpesvirus (HHV)-6 encephalitis, systemic lupus erythematosus, Hashimoto thyroiditis, Sjogren syndrome, antiphospholipid syndrome, and primary angiitis of the CNS [4]. In addition, evaluation for an associated neoplastic entity may require doing a computed tomography (CT) of the chest, abdomen, and pelvis or a positron emission tomography (PET) scan and pelvic or scrotal ultrasound.


EEG


The EEG in cases of limbic encephalitis is almost invariably abnormal, as noted above. There is often diffuse slowing in the theta to delta range. There may be evidence of epileptiform discharges over one or both temporal lobes. Seizures may be clinical or subclinical, and in some cases NCSE or epilepsia partialis continua (EPC) may be seen [5]. An extreme delta-brush pattern may be seen in some cases of anti-NMDA receptor encephalitis, illustrated in Fig. 1 [6]. The use of cEEG may at times be helpful to identify recurrent NCS. Samples of EEG changes seen in cases of limbic encephalitis, namely, in anti-NMDA receptor and anti-voltage-gated potassium channel (VGKC) complex encephalitides may be found in Figs. 2 and 3. In cases of anti-NMDA receptor encephalitis, abnormal orofacial dyskinesias may mimic seizures, and cEEG shows no associated epileptiform correlates with these events.

A328697_1_En_18_Fig1_HTML.gif


Fig. 1
Interictal EEG in a patient with anti-NMDA receptor encephalitis with evidence of diffuse background delta slowing and extreme delta brush with superimposed beta activity riding on the delta wave seen at the arrows


A328697_1_En_18_Fig2_HTML.gif


Fig. 2
EEG showing onset of a left anterior quadrant nonconvulsive seizure in a 16-year-old patient with anti-NMDA receptor encephalitis


A328697_1_En_18_Fig3_HTML.gif


Fig. 3
EEG showing a convulsive seizure in a patient with anti-VGKC complex encephalitis. The EEG record in a marks the onset of the seizure and the one in b shows the ictal pattern 2 min into the seizure


Treatment


In patients with autoimmune limbic encephalitis, it is important to establish whether there is a tumor associated with the encephalitis. If a tumor is found, removal of the tumor allows for neurologic improvement. In many cases a tumor may not be present and immunotherapy is needed. Often, a course of steroids or intravenous immunoglobulin (IVIG) is tried with or without plasma exchange. Many patients also require additional immunotherapy with rituximab, cyclophosphamide, or other immunomodulatory agents. It is well known that autoimmune encephalitides related to cell surface antigens respond to immunotherapy. These patients often recover over few months, and some may require continued use of immunotherapy.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 12, 2017 | Posted by in NEUROLOGY | Comments Off on Autoimmune, Infectious, and Metabolic NCSE/NCS

Full access? Get Clinical Tree

Get Clinical Tree app for offline access